Memphis Pharmaceuticals & Chemical Industries

CASE:MPCI Stock Report

Market Cap: ج.م296.8m

Memphis Pharmaceuticals & Chemical Industries Past Earnings Performance

Past criteria checks 6/6

Memphis Pharmaceuticals & Chemical Industries has been growing earnings at an average annual rate of 57.8%, while the Pharmaceuticals industry saw earnings growing at 15.1% annually. Revenues have been growing at an average rate of 16.3% per year. Memphis Pharmaceuticals & Chemical Industries's return on equity is 106.6%, and it has net margins of 28.2%.

Key information

57.8%

Earnings growth rate

56.7%

EPS growth rate

Pharmaceuticals Industry Growth9.8%
Revenue growth rate16.3%
Return on equity106.6%
Net Margin28.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Memphis Pharmaceuticals & Chemical Industries makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CASE:MPCI Revenue, expenses and earnings (EGP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,089308920
30 Jun 24872191880
31 Mar 24888222840
31 Dec 23791146780
30 Sep 23696103690
30 Jun 2366490770
31 Mar 2358588750
31 Dec 2259792770
30 Sep 2257382810
30 Jun 2255174720
31 Mar 2252937730
31 Dec 2150733690
30 Sep 2151039860
30 Jun 2151842760
31 Mar 2150638280
31 Dec 2050633300
30 Sep 2051024250
30 Jun 2048817240
31 Mar 20463-3560
31 Dec 19437-4460
30 Sep 19401-11220
30 Jun 19363-25220
31 Mar 19347-33240
31 Dec 18337-45210
30 Sep 18339-52210
30 Jun 18340-47210
31 Mar 18291-67230
31 Dec 17266-56220
30 Sep 17255-42210
30 Jun 17248-34210
31 Mar 173022170
31 Dec 163212180
30 Sep 163130200
30 Jun 163540190
31 Mar 163482530
31 Dec 153860530
30 Sep 15409-4510
30 Jun 15392-10510
31 Mar 15417-13520
31 Dec 14411-12490
30 Sep 14402-7490
30 Jun 143980480
31 Mar 144244500

Quality Earnings: MPCI has high quality earnings.

Growing Profit Margin: MPCI's current net profit margins (28.2%) are higher than last year (14.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: MPCI has become profitable over the past 5 years, growing earnings by 57.8% per year.

Accelerating Growth: MPCI's earnings growth over the past year (199.9%) exceeds its 5-year average (57.8% per year).

Earnings vs Industry: MPCI earnings growth over the past year (199.9%) exceeded the Pharmaceuticals industry 37.9%.


Return on Equity

High ROE: MPCI's Return on Equity (106.6%) is considered outstanding.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 04:58
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Memphis Pharmaceuticals & Chemical Industries is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution